The brief negative symptom scale: psychometric properties.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Schizophrenia bulletin

• Publication date

  2011-03-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1093/schbul/sbq059PMID 20558531PMCID PMC3044634
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• ALCOHOL AND OTHER DRUG ABUSE

  2012cited by this paper
• Anticipatory and consummatory components of the experience of pleasure in schizophrenia: cross-cultural validation and extension.

  2010cited by this paper
• Differences in glucose tolerance between deficit and nondeficit schizophrenia.

  2009cited by this paper
• Psychopathology and neuropsychological impairments in deficit and nondeficit schizophrenia of Chinese origin.

  2008cited by this paper
• Anhedonia in schizophrenia: distinctions between anticipatory and consummatory pleasure.

  2007cited by this paper
• Food and Drug Administration perspective on negative symptoms in schizophrenia as a target for a drug treatment claim.

  2006cited by this paper
• Deficit schizophrenia: association with serum antibodies to cytomegalovirus.

  2006cited by this paper
• Anticipatory and consummatory components of the experience of pleasure: A scale development study

  2006cited by this paper
• The NIMH-MATRICS consensus statement on negative symptoms.

  2006cited by this paper
• The structure of negative symptoms within schizophrenia: implications for assessment.

  2006cited by this paper
• Three dimensions of clinical symptoms in elderly patients with schizophrenia: prediction of six-year cognitive and functional status.

  2006cited by this paper
• Summer birth and deficit schizophrenia: a pooled analysis from 6 countries.

  2004cited by this paper
• Letter to the editor. Substance abuse and the heterogeneity of schizophrenia a population-based study

  2003cited by this paper
• Substance abuse and the heterogeneity of schizophrenia a population-based study.

  2003cited by this paper
• Summer birth and deficit schizophrenia.

  2003cited by this paper
• Dementia praecox and paraphrenia

  2002cited by this paper
• Summer birth and deficit schizophrenia in Dumfries and Galloway, southwestern Scotland.

  2002cited by this paper
• SUMMER BIRTH AND DEFICIT SCHIZOPHRENIA: CANTABRIA, SPAIN

  2002cited by this paper
• Summer Birth and Deficit Schizophrenia in Nithsdale, Scotland

  2001cited by this paper
• Summer Birth and Deficit Schizophrenia in the Epidemiological Catchment Area Study

  2001cited by this paper
• A separate disease within the syndrome of schizophrenia.

  2001cited by this paper
• Risk factors for the deficit syndrome of schizophrenia.

  2000cited by this paper
• Summer birth and the deficit syndrome of schizophrenia.

  1998cited by this paper
• The deficit syndrome in the DSM-IV Field Trial. Part II. Depressive episodes and persecutory beliefs.

  1996cited by this paper
• The deficit syndrome in the Suffolk County Mental Health Project.

  1996cited by this paper
• The deficit syndrome in the DSM-IV Field Trial: I. Alcohol and other drug abuse.

  1996cited by this paper
• Domains of Psychopathology: An Approach to the Reduction of Heterogeneity in Schizophrenia

  1994cited by this paper
• Factor structure of the negative symptom assessment.

  1994cited by this paper
• Case identification and stability of the deficit syndrome of schizophrenia.

  1993cited by this paper
• Validation of the 16-item Negative Symptom Assessment.

  1993cited by this paper
• The Schedule for the Deficit syndrome: an instrument for research in schizophrenia.

  1989cited by this paper
• The Scale for the Assessment of Negative Symptoms (SANS): Conceptual and Theoretical Foundations

  1989cited by this paper
• The positive and negative syndrome scale (PANSS) for schizophrenia.

  1987cited by this paper
• The two-syndrome concept: origins and current status.

  1985cited by this paper
• Department of Health, Education, and Welfare.

  1976cited by this paper
• The diagnosis and understanding of schizophrenia. Part III. Speculations on the processes that underlie schizophrenic symptoms and signs.

  1974cited by this paper
• A Case of Homicidal Mania

  1860cited by this paper

• A dual-marker peripheral signature of IL-6 elevation and NEAT1 reduction in negative-symptom schizophrenia: a cross-sectional study

  2026cites this paper
• Finding a Medication for Negative Symptoms in Schizophrenia: Why So Many Failures?

  2026cites this paper
• Asociality in schizophrenia: A review of historical foundations, measures, mechanisms, and treatments.

  2026cites this paper
• Efficacy and long-term effects of intermittent theta burst stimulation on negative symptoms in schizophrenia: a systematic review and meta-analysis

  2026cites this paper
• Computational phenotypes underlying effort-based decision-making and negative symptoms in a transdiagnostic severe mental illness sample.

  2026cites this paper
• From episodic memory to functioning in schizophrenia and related psychoses: A neurocognitive model - protocol paper

  2026cites this paper
• Treating Unmet Needs in Psychiatry (TUNE-UP): targeted service increases out-patient initiations of clozapine

  2026cites this paper
• Resting-state gamma activity as a discriminative marker for cognitive subtypes in psychosis.

  2026cites this paper
• Treatment trials for negative symptoms in schizophrenia.

  2025cites this paper
• French Validation of the Brief Negative Symptom Scale (BNSS)

  2025cites this paper
• Three dimensions of speech coherence in people with early psychosis and their family members

  2025cites this paper
• Clinical and Inflammatory Correlates of Negative Symptom Dimensions in Schizophrenia: Cross-Sectional Evidence for Neutrophil-to-Lymphocyte Ratio Associations With Motivational Deficits in Hospitalized Patients

  2025cites this paper
• Measuring the clinical dimensions of negative symptoms through the Positive and Negative Syndrome Scale.

  2025influential citation
• Peripheral Microvascular and Cerebral White Matter Dysfunction in Schizophrenia: Implications of a Body-Brain Endothelial Pathophysiology.

  2025cites this paper
• Illness Severity in Psychotic Disorders Amplifies Anterior Insula’s Sensitivity to Unreciprocated Smiles

  2025cites this paper
• Why clinical neuropsychology matters in schizophrenia care

  2025cites this paper
• Cerebellar-Prefrontal Connectivity Predicts Negative Symptom Severity Across the Psychosis Spectrum

  2025cites this paper
• Validation of the Lithuanian version of the Brief Negative Symptoms Scale

  2025influential citation
• Role of Serotonin in the Neurobiology of Schizophrenia and Association With Negative Symptoms.

  2025cites this paper
• The role of low subcortical iron, white matter myelin, and oligodendrocytes in schizophrenia: a quantitative susceptibility mapping and diffusion tensor imaging study

  2025cites this paper
• Efficacy of adjunctive antidepressants in treating negative symptoms of schizophrenia: a systematic review and network meta-analysis

  2025cites this paper
• Role of childhood trauma in interoception and alexithymia in schizophrenia.

  2025cites this paper
• Pharmacological Interventions for Negative Symptoms in Schizophrenia: A Systematic Review of Randomised Control Trials

  2025cites this paper
• Early career psychiatrists’ ability to evaluate and manage negative symptoms of schizophrenia – Results from a European survey

  2025cites this paper
• Dysfunctional Beliefs and Their Psychological Pathways to Negative Symptoms and Functioning in Schizophrenia Spectrum Disorders.

  2025cites this paper
• Distinct cortical inhibitory profiles in schizophrenia and bipolar disorder: A TMS-EEG study of GABAb function.

  2025cites this paper
• Aberrant information flow within resting-state triple network model in schizophrenia-An EEG effective connectivity study.

  2025cites this paper
• Alpha band EEG resting-state dynamic functional source connectivity in first-episode schizophrenia

  2025cites this paper
• Functional Connectivity in Chronic Schizophrenia: An EEG Resting‐State Study with Corrected Imaginary Phase‐Locking

  2025influential citation
• The Role of Negative Symptoms on the Continuum of Psychosis Risk as a Mediator of the Relationship Between Personality and Functioning in Individuals With Psychotic‐Like Experiences

  2025cites this paper
• Environmental deprivation is associated with reward processing impairments and negative symptoms in schizophrenia.

  2025cites this paper
• Characterising negative symptoms in schizophrenia: CHANSS study protocol

  2025cites this paper
• Influence of recent cannabis use on altered spectral entropy modulation and connectivity strength in patients with psychosis.

  2025cites this paper
• Memantine for the Treatment of Primary Negative Symptoms in Schizophrenia: A Meta-analysis of Randomized Controlled Trials

  2025cites this paper
• Distinct cognitive trajectories in the early course of psychosis are associated with clinical and functional outcomes longitudinally

  2025influential citation
• Understanding caffeine's impact on sustained attention in early phase psychosis: Unveiling cognitive insights through the use of EEG.

  2025cites this paper
• Computational linguistic investigation in schizophrenia and autism spectrum disorders.

  2025cites this paper
• The CARE project – study protocol and pilot results from the Polish population

  2025cites this paper
• The role of mindfulness training supported by virtual reality in the nonpharmacological treatment of schizophrenia-research design

  2025cites this paper
• The GPR139 agonist TAK-041 produces time-dependent alterations to cerebral blood flow and reward system function in patients with schizophrenia: a randomised placebo-controlled trial.

  2025cites this paper
• Alleviating negative symptoms in schizophrenia using a virtual reality-based therapy targeting social reward learning (ENGAGE): Protocol for a randomised, controlled, assessor-blind pilot study

  2025cites this paper
• Blood and Neuronal Extracellular Vesicle Mitochondrial Disruptions in Schizophrenia

  2025cites this paper
• Quantifying facial affect changes in psychotic disorders with machine learning.

  2025cites this paper
• Cortical Iron in Schizophrenia: A Quantitative Susceptibility Mapping and Diffusion Tensor Imaging MRI Study

  2025cites this paper
• Assessment of Motivation in Schizophrenia: Patient- and Clinician-Rated Outcomes.

  2025cites this paper
• Diagnostic digital phenotyping in schizophrenia-spectrum disorders: a systematic review

  2025cites this paper
• Negative Symptoms in Schizophrenia: An Update on Research Assessment and the Current and Upcoming Treatment Landscape

  2025cites this paper
• Applied pharmacogenetics to predict response to treatment of first psychotic episode: study protocol

  2025cites this paper
• Systematic Review of Self-Assessment Scales for Negative Symptoms in Schizophrenia

  2025cites this paper
• Assessment of Negative Symptoms in Schizophrenia: From the Consensus Conference-Derived Scales to Remote Digital Phenotyping

  2025cites this paper
• Utility of Digital Phenotyping Based on Wrist Wearables and Smartphones in Psychosis: Observational Study

  2025cites this paper
• Impact of Early Auditory Processing on Negative Symptom Response to Cognitive Remediation for Schizophrenia.

  2025cites this paper
• Secondary Negative Symptoms in Schizophrenia: Psychopathological Characteristics and Approachs to Differential Diagnostics

  2025cites this paper
• Prevalence of Primary, Prominent, and Predominant Negative Symptoms of Schizophrenia in Routine Inpatient Psychiatric Care

  2025cites this paper
• Deconstructing Emotion Regulation in Schizophrenia: The Nature and Consequences of Positive Emotion Up-Regulation Abnormalities

  2025cites this paper
• Is There a Link Between Type 2 Diabetes Mellitus and Negative Symptoms in Schizophrenia? A Scoping Review

  2025cites this paper
• Moderation Effect of Emotional Expressivity on the Associations Between Schizotypal Traits, Autistic Traits and Social Pleasure

  2025cites this paper
• Resource deprivation in the home environment is associated with negative symptoms in outpatients with Schizophrenia

  2025cites this paper
• Disorganized Striatal Functional Connectivity as a Partially Shared Pathophysiological Mechanism in Both Schizophrenia and Major Depressive Disorder: A Transdiagnostic fMRI Study

  2025cites this paper
• Exploratory analysis of the relationship between striatal connectivity and apathy during phosphodiesterase 10 inhibition in schizophrenia: findings from a randomized crossover trial

  2025cites this paper
• COSMIN systematic review and meta-analysis of the measurement properties of the Positive and Negative Syndrome Scale (PANSS)

  2025cites this paper
• [A dimensional approach to negative symptoms in psychiatric disorders].

  2025cites this paper
• Using the grip strength effort task to measure reward processing dysfunction in schizophrenia and major depressive disorder

  2025cites this paper
• Negative symptoms in psychosis: A scoping review of qualitative studies.

  2025cites this paper
• Clinical high risk for psychosis in bipolar disorder: Clinical features, cognition and functioning.

  2025cites this paper
• Treating Unmet Needs in Psychiatry (TUNE-UP): A Targeted Service Increases Outpatient Initiations of Clozapine

  2025cites this paper
• Unravelling the Complexity of Schizophrenia: A Comprehensive Review

  2025cites this paper
• Inflammation is associated with avolition and reduced resting state functional connectivity in corticostriatal reward circuitry in patients with schizophrenia

  2025cites this paper
• Unpacking the Anhedonia Paradox Across the Psychosis Continuum: The Role of the Positivity Offset

  2025influential citation
• Assessing negative symptoms of schizophrenia in the context of remote independent ratings: a psychometric evaluation of BNSS and PANSS.

  2025cites this paper
• Gait examination in catatonia using 3D optical markerless motion tracking.

  2025cites this paper
• Negative symptoms, cognition, and community functioning in early psychosis.

  2025cites this paper
• Cortisol response patterns to stress correlated to white matter integrity and duration of illness in patients with schizophrenia.

  2025cites this paper
• Mapping the trajectory of psychotic symptoms and their interaction with antipsychotic treatment: a longitudinal network intervention study

  2025cites this paper
• How do negative symptoms and social cognitive impairments overlap? Clustering analyses on patients living with schizophrenia-spectrum disorder

  2025cites this paper
• Relationship between negative symptoms, cognitive function and social function in schizophrenia: new insight from a network analysis

  2025influential citation
• Anhedonia is associated with impaired memory for positive emotional stimuli in individuals with schizophrenia.

  2025cites this paper
• Passive sensing of anhedonia and amotivation in a transdiagnostic sample.

  2025cites this paper
• Anhedonia and Negative Symptoms in First-Episode Psychosis: A Systematic Review and Meta-Analysis of Prevalence, Mechanisms, and Clinical Implications

  2025cites this paper
• Blood and neuronal extracellular vesicle mitochondrial disruptions in schizophrenia

  2025cites this paper
• Validation of the Romanian version of the brief negative symptom scale in a heterogeneous schizophrenia inpatient sample

  2025influential citation
• Virtual reality-based versus standard cognitive behavioral therapy for paranoia in schizophrenia spectrum disorders: a randomized controlled trial

  2025cites this paper
• Effect of transcranial magnetic pulses on cortical network connectivity in schizophrenia.

  2025cites this paper
• Remote Assessment of Emotion Dynamics in Schizophrenia using a Multimodal Dialog System

  2025cites this paper
• Gesture Impairments in Schizophrenia: Distinct Roles of Negative Symptoms and Formal Thought Disorder.

  2025cites this paper
• Reduced Brain Iron is Associated with Striatal Hyperdopaminergia in Schizophrenia and Unrelated to Neuromelanin and Myelin Imaging Measures: A Quantitative Susceptibility Mapping MRI and PET Study

  2025cites this paper
• Assessing tDCS efficacy in reducing negative symptoms in schizophrenia spectrum disorders: A systematic review and meta-analysis.

  2025cites this paper
• Gesture deficits in psychosis and the combination of group psychotherapy and transcranial magnetic stimulation: A randomized clinical trial

  2025cites this paper
• Aberrant visual attention is associated with social judgements of attractiveness and negative symptoms in schizophrenia.

  2025cites this paper
• Associated factors of the quality of therapeutic alliance in people with severe mental illnesses: A systematic review.

  2025cites this paper
• Psychometric Properties and Factor Structure of the Arabic Translation of the Brief Negative Symptom Scale

  2025influential citation
• Elevated defeatist performance beliefs predict state increases in negative symptoms in daily life in clinical high-risk for psychosis youth: implications for mobile health treatments.

  2025cites this paper
• The Role of Immunoinflammatory Factors in the Development of Negative Symptoms in Schizophrenia

  2025cites this paper
• Clozapine (and norclozapine) concentrations are correlated with functioning, disability and side-effects when patients are treated with clozapine without the availability of therapeutic drug monitoring: A study of treatment-resistant schizophrenia inpatients

  2025cites this paper
• Confirmatory factor analysis of competing PANSS negative symptom models: data from OPTiMiSE first-episode schizophrenia study

  2025cites this paper
• Probabalistic reinforcement learning impairments predict negative symptom severity and risk for conversion in youth at clinical high-risk for psychosis

  2025cites this paper
• Investigating the causal pathways among psychopathological variables, cognitive impairment, and real-life functioning in people with schizophrenia

  2025cites this paper
• Predicting clinical outcomes in a blended care intervention for early psychosis: Acceptance and Commitment Therapy in Daily-Life (ACT-DL)

  2025cites this paper
• Neurobiological fingerprints of negative symptoms in schizophrenia identified by connectome‐based modeling

  2025cites this paper
• The Nature of Mental Imagery and Its Relationship With Amotivational Psychopathology in People With Schizophrenia Spectrum Disorders.

  2024cites this paper